One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Public health funding in England: death by a thousand cuts
doi : 10.1016/S2468-1253(21)00394-0
Volume 6, Issue 12, December 2021, Page 971
Alcohol-related cirrhosis and liver cancer: a call for inclusion in non-communicable disease action plans
Ajeet SinghBhadoriaaArchismanMohapatrab
Spore-forming probiotics for functional dyspepsia
PatrickMullieaPatrikVankrunkelsvena
Spore-forming probiotics for functional dyspepsia – Authors’ reply
LucasWautersabTimVanuytselab
Artificial intelligence in colonoscopy
ShellySofferadeAdiLahatbfEyalKlangacfg
Artificial intelligence in colonoscopy
DaisukeMurakamiabMasayukiYamatobMakotoAraiaTakayoshiNishinoa
Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes
Jennifer RSnaithaMarkDantabJerry RGreenfielda
Metabolic-associated fatty liver disease in children and adolescents: Mexican experience
NahumMéndez-SánchezabLuis EDÃaz-OrozcoabClaudiaSantamarÃa-ArzacJosé AOrozco-MoralesadPatricia GMedina-Bravoae
Features of gastrointestinal amyloidosis
AkiraHokamaaJiroFujitab
Features of gastrointestinal amyloidosis – Authors’ reply
GonzaloLatorreabJosé IgnacioVargasabAlbertoEspinoab
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
James LAlexanderabChristian PSelingercNickPowellabBritish Society of Gastroenterology Inflammatory Bowel Disease section and the Inflammatory Bowel Disease Clinical Research Group
SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
RaniaSelimabJudithWellensacLukeMarlowaJack JSatsangia
Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa
ProfC WendySpearmanPhDaMaryAfiheneFWACPbOmoladeBetikuFMCPathcBilalBobatMBChBdeLinaCunhaMDfChrisKassianidesFCP (SA)gLeolinKatsidziraDPhilhHailemichael DMekonnenPhDiPonsianoOcamaPhDjProfOlusegunOjoMDkImranParukCert Endo Metab (SA)lProfChristianTzeutonPhDmMark WSonderupMMedaGastroenterology and Hepatology Association of sub-Saharan Africa (GHASSA)
Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa
ProfC WendySpearmanPhDaAbdelmounemAbdoMDbAggreyAmbaliPhDcYaw AAwukuFWACPdChrisKassianidesFCP (SA)eOlufunmilayo ALesiMDfMargarethNdomondo-SigondaPhDcCharles AOnyekwereMDgJohnRwegashaFRCP (Lond)hAbate BShewayeMDiMark WSonderupMMedaGastroenterology and Hepatology Association of sub-Saharan Africa (GHASSA)
